Hanmi releases dexibuprofen ER tablets

Published: 2009-03-19 06:58:00

Updated: 2009-03-19 06:58:00

Hanmi Pharm said it has newly launched an extended release form of dexibuprofen 300 mg tablets for relief of sign and symptoms of osteoarthritis, rheumatoidal disorders such as osseous rheumatism, ankylosing spondilitis, juvenile arthritis, muscular rheumatism, degenerative joint diseases.

Twi...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK